Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Retinopathy of Prematurity, Neurodevelopmental Disorders or Macular Edema
and you are
over 30
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Retinopathy of prematurity (ROP) is a disorder of development of the neural retina and its vasculature that may impact vision in vulnerable preterm neonates for a lifetime. This study utilizes new technology to determine visual and neurological development of very preterm infants in the intensive care nursery, during a period of rapid growth of the retina, optic nerve and brain. The long-term goal of this study is to help improve preterm infant health care via objective bedside imaging and analysis that characterizes early critical indicators of poor vision, neurological development and ROP, which will rapidly translate to better early intervention and improved future vision care.

Provided treatments

  • Device: Swept Source OCT
  • Other: Magnetic Resonance Imaging
  • Other: Scavenged blood collection
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02887157. The sponsor of the trial is Duke University and it is looking for 160 volunteers for the current phase.
Official trial title:
Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care